Search by Drug Name or NDC
NDC 23155-0603-51 clindamycin palmitate hydrochloride 75 mg/5mL Details
clindamycin palmitate hydrochloride 75 mg/5mL
clindamycin palmitate hydrochloride is a ORAL GRANULE, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is CLINDAMYCIN PALMITATE HYDROCHLORIDE.
MedlinePlus Drug Summary
Clindamycin is used to treat certain types of bacterial infections, including infections of the lungs, skin, blood, female reproductive organs, and internal organs. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria. Antibiotics such as clindamycin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 23155-0603-51Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clindamycin
Product Information
| NDC | 23155-0603 |
|---|---|
| Product ID | 23155-603_6b2e0bbb-397e-49b2-aaea-3ec3896b8beb |
| Associated GPIs | 16220020222120 |
| GCN Sequence Number | 009346 |
| GCN Sequence Number Description | clindamycin palmitate HCl SOLN RECON 75 MG/5 ML ORAL |
| HIC3 | W1K |
| HIC3 Description | LINCOSAMIDE ANTIBIOTICS |
| GCN | 40860 |
| HICL Sequence Number | 019818 |
| HICL Sequence Number Description | CLINDAMYCIN PALMITATE HCL |
| Brand/Generic | Generic |
| Proprietary Name | clindamycin palmitate hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | clindamycin palmitate hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GRANULE, FOR SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/5mL |
| Substance Name | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207047 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0603-51 (23155060351)
| NDC Package Code | 23155-603-51 |
|---|---|
| Billing NDC | 23155060351 |
| Package | 1 BOTTLE in 1 CARTON (23155-603-51) / 100 mL in 1 BOTTLE |
| Marketing Start Date | 2018-05-11 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.18196 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | CLINDAMYCIN (PEDI) 75 MG/5 ML |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |